Patient support programmes generate vast amounts of data, but the real question is whether that data can drive meaningful action and genuine improvement. Many organisations collect and report on patient support metrics
The International Chamber of Commerce has revised its arbitration rules, with the changes taking effect on June 1, 2026, for all newly commenced proceedings. The ICC, one of the world’s leading arbitral
More
Prisma Health’s acquisition of Erlanger Health stands out as one of the most significant hospital consolidation deals completed during the summer of 2026. Sanford Health’s purchase of North Memorial Health also drew
More
Micro-cap stocks have long sat in the shadows of their larger counterparts, attracting little attention from institutional investors or mainstream financial media. A veteran fund manager is now making the case that
More
Reform UK leadership contender Robert Jenrick has pledged to raise the tax-free personal allowance from £12,570 to £15,000 if the party wins power at the next general election. Jenrick outlined the proposal
More
Reform UK held its first-ever Business Day at its annual conference in Birmingham, hoping to convince industry chiefs the party is ready for government. Policy guru Dr James Orr described Reform’s economic
More
Silicon Valley’s biggest technology companies are facing a new legal challenge over whether hiring sprees at AI startups amount to unlawful acquisitions under US antitrust law. The question is not whether a
More
Chaka Patterson, founder and CEO of Chaka Strategy, has a blunt message for lawyers who think legal expertise alone will carry them to the top. Patterson, also the author of The Hot
More
Ford Motor Company (F) shares moved higher as investors weighed a reported drop in August sales figures against continued strong performance from its flagship F-Series truck lineup. The F-Series has long been
More
Iceland executive chairman Lord Richard Walker has declared his intention to open a supermarket on the Falkland Islands as a diplomatic dispute over the territory reignites. Walker announced the plan via LinkedIn,
More
Major pharmaceutical companies including Roche, GSK, and Novartis are at the centre of a flurry of deal-making and drug pricing agreements reshaping the industry landscape. GSK moved first among the late movers
More